whitepaper
Whitepaper: Manufacturing with Bruker’s Fourier PAT
Maximize the effectiveness and benefits of data-driven, real-time control, on-line NMR analysis coupled with process analytical technology (PAT).
List view / Grid view
Bruker
whitepaper
Whitepaper: The Use of Positron Emission Tomography (PET) in Pre-clinical Pharmaceutical Research
Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific metabolic functions.
news
Bruker introduces scimaX™ MRMS for novel phenomics workflows, and further enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
news
Bruker launches new FT-IR R&D Spectrometer INVENIO™
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications...
news
Bruker introduces the new CTX™ Portable XRF Analyzer
Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width...
whitepaper
Biochemical Assay Development Using Novel MALDI High-Throughput Screening System
This whitepaper focuses on developing biochemical assays where substrate and product are small molecules using a novel MALDI-HTS system...
whitepaper
Poster note: Fully automated structure verification of organic compounds by combining high resolution accurate MS with NMR data analysis
Here we describe a new approach which automates structure verification for (synthetic) chemists...
whitepaper
Poster note: MALDI high-throughput screening beyond 100,000 samples per day in drug discovery
This work focuses on the improvement of MALDI-TOF automation parameters to further increase sample analysis speed in HTS assays to more than 100,000 samples per day...
whitepaper
Application note: High-throughput Screening of Deubiquitylase enzyme (DUB) activity/specificity and inhibitor screening by MALDI-TOF mass spectrometry
In biopharmaceutical laboratories, there is a growing need for high-throughput, yet sensitive methodologies to characterize deubiquitylase enzymes (DUBs) and DUB inhibitors...
whitepaper
Application note: Bruker Optik – TANDEM FT-NIR for on-line tablet characterisation
Pharmaceutical manufacturers are required to enhance their critical quality performances. This is being encouraged by the FDA, which is pushing towards using modern process analytical technology (PAT) to ensure the quality of the final product.
